CN Patent

CN104803916B — 用作选择性雄激素受体调节剂(sarms)的杂环衍生物

Assigned to Janssen Pharmaceutica NV · Expires 2017-08-11 · 9y expired

What this patent protects

本发明涉及新的杂环衍生物、包含它们的药用组合物和它们在治疗由雄激素受体介导的病症和疾病中的用途。

USPTO Abstract

本发明涉及新的杂环衍生物、包含它们的药用组合物和它们在治疗由雄激素受体介导的病症和疾病中的用途。

Drugs covered by this patent

elacestrant-hydrochloride (ELACESTRANT HYDROCHLORIDE)

Patent Metadata

Patent number: CN104803916B
Jurisdiction: CN
Classification: —
Expires: 2017-08-11
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Pharmaceutica NV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.